Latest News & Features
Americas
Two rivals withdrew from acquisition process| Agreement provides access to blockbuster medicines | Janssen Global Services | Sanofi. 13 December 2022
article
Firm promotes life sciences lead | New managing partner will play a role in international IP services group. 8 December 2022
Big Pharma
Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna. 8 December 2022
Americas
Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about
the controversial patent waiver. 8 December 2022
Big Pharma
New addition comes from Fieldfisher | Practice will extend across the US, UK and Continental Europe | renewables and cleantech. 6 December 2022
Big Pharma
Agency found to have breached deal regarding research | Pharma firm accused of piggybacking on public research| Centers for Disease Control and Prevention. 6 December 2022
Big Pharma
Medicines Patent Pool deals have given 20 million people access to HIV treatment | Full list of sub-licensees. 6 December 2022
Americas
Ex-partners collaborated on a clinical study for a cancer treatment | Pharma firm insists that it has exclusive licensing rights | MSD | John Hopkins. 1 December 2022
Big Pharma
As the ‘UK+’ exhaustion regime is set to continue for now, Rebecca Anderson-Smith of Mewburn Ellis explores how pharma firms should protect their rights. 1 December 2022
article
Following the entering into force of Regulation 2017/746 of the European Parliament on in vitro diagnostic medical devices, an increasing number of medical products labelled “for research use only” rather than products bearing CE marking will be launched. Implications for patent litigation will be discussed based on relevant case law. 29 November 2022